Reports [inpr]
International [idcn]
Workshop [edac]
Drug [phsu]
Reaction [ftcn]
Lipodystrophy [dsyn]
HIV [virs]
International [idcn]
Workshop [edac]
Reactions, Adverse Drug [inpo]
Lipodystrophy [dsyn]
HIV [virs]
Provided [acty]
Presentation [idcn]
Basic [ftcn]
Clinical Research [resa]
Focused [spco]
pathogenesis [ftcn]
Management [ocac]
Lipodystrophy [dsyn]
adverse events [fndg]
Associated [qlco]
Antiretroviral therapy [topp]
New [tmco]
Data [idcn]
Reported [inpr]
Contribution [acty]
Antiretroviral therapy [topp]
HIV infection [dsyn]
development [phsf]
Metabolic [ftcn]
Abnormalities [cgab]
Patients [podg]
Lipodystrophy [dsyn]
Including [ftcn]
Insulin Resistance [patf]
Dyslipidaemia [dsyn]
Associated [qlco]
Increased [qnco]
Risk [qlco]
Diabetes [dsyn]
Cardiovascular disease [dsyn]
Addition [ftcn]
Role [socb]
HIV [virs]
Antiretroviral therapy [topp]
Bone [bpoc]
Liver [bpoc]
Kidney disease [dsyn]
Major [qlco]
Focus [spco]
Data [idcn]
Presented [idcn]
Concern [idcn]
Identification [menp]
Evaluation [ftcn]
risk factors [qnco]
Appropriate [qlco]
Surrogate Markers [qlco]
Cardiovascular disease [dsyn]
Risk [qlco]
Outcome [ftcn]
long-term treatment [hlca]
Complex [qlco]
risk factors [qnco]
Data [idcn]
IMPACT [gngm]
Race [popg]
Age [orga]
Gender [orga]
progression [patf]
Metabolic disease [dsyn]
Complications [patf]
Different [qlco]
HIV [virs]
Infected [ftcn]
Population [qnco]
Advance [medd]
development [phsf]
Pharmacovigilance [resa]
Reporting [hlca]
System [ftcn]
Resource [idcn]
Limited [ftcn]
setting [ftcn]
IMPACT [gngm]
health care policy [rnlw]
Provisional [idcn]
patient care [hlca]
